Similar Stories to Initial Data From A Pair Of Clinical Trials May Revive Interest In Arthritis Drugs As Covid-19 Treatments on Bing News

MarketWatch.com - Top Stories, MarketWatch
Sun, 09/20/2020 - 8:46am

There is some renewed hope for rheumatoid arthritis drugs like Eli Lilly’s Olumiant and Roche’s Actemra as possible COVID-19 treatments after a series of clinical setbacks this summer seemed to close the door on the category’s potential.

PREV NEXT
BING NEWS:
  • Still No Evidence COVID-19 Vaccination Increases Cancer Risk, Despite Posts
    The body then mounts an immune response to the spike protein, preparing the immune system to respond to the virus that causes COVID-19 in the future. Link to this Clinical trials ... a gross ...
    05/2/2024 - 1:00 pm | View Link
  • Study: Antibiotic use in moderate COVID-19 linked to clinical deterioration
    Antibiotic treatment of adults hospitalized with moderate COVID-19 is associated with clinical deterioration, despite the drugs being given to over 40% of patients, according to new research being ...
    04/26/2024 - 3:56 am | View Link
  • Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
    The Company is advancing the clinical development of Bucillamine by leveraging the published research and data ... based drugs and provided a rationale to test thiol-based drugs such as Bucillamine as ...
    04/22/2024 - 7:59 pm | View Link
  • More
PREV NEXT

 

PREV NEXT
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

Movies With Butter More Movie News

More Business News